コンテンツへスキップ
Merck
  • A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans.

A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans.

Psychiatry research (2013-01-02)
Jennifer C Naylor, Trygve R Dolber, Jennifer L Strauss, Jason D Kilts, Timothy J Strauman, Daniel W Bradford, Steven T Szabo, Nagy A Youssef, Kathryn M Connor, Jonathan R T Davidson, Christine E Marx
要旨

Subthreshold posttraumatic stress disorder (PTSD) is associated with increased risk for suicidality, depression, and functional impairment. We thus conducted a small (N=12) pilot randomized controlled trial (RCT) with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) era veterans. Hospital Anxiety and Depression Scale (HADS) scores improved by 30.4% in the paroxetine group. Paroxetine may have promise for subthreshold PTSD.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
パロキセチン 塩酸塩 ヘミ水和物, ≥98% (HPLC), powder
Supelco
Paroxetine maleate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
パロキセチン マレイン酸塩, ≥98% (HPLC), solid
パロキセチン 塩酸塩 ヘミ水和物, European Pharmacopoeia (EP) Reference Standard
システム適合性用パロキセチン, European Pharmacopoeia (EP) Reference Standard